Researchers use the CRISPR/Cas9 gene editing approach to limit herpesviruses replication.
In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.
In addition, Argene will provide BioMérieux with a portfolio of molecular tests for diagnosing infectious diseases in transplant and other immunocompromised patients.
BioMérieux plans to migrate Argene's test products onto a molecular diagnostic platform it is co-developing with Biocartis.
Quest's Focus Diagnostics gets CE Mark for Simplexa EBV and BK virus tests; Cepheid gets FDA nod for Xpert Flu test.
Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.
King's College London researchers examine the influence of school type and genetics on academic achievement.
FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.
In Science this week: early life experience influence somatic variation in the genome, and more.